Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
AVTX on Nasdaq
There are no Buy or Sell transactions made by Christopher Ryan Sullivan since 12/22/2023
Holdings reported by Christopher Ryan Sullivan for Avalo Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
72.6K |
$37.7K |
$0.52 |
Aug 13, 2024 |
Direct |
Common Stock |
|
| Common Stock |
6 |
$3.12 |
$0.52 |
Aug 13, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
187K |
|
|
Aug 13, 2024 |
Direct |
Common Stock |
|
Transactions reported by Christopher Ryan Sullivan for Avalo Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.